Zobrazeno 1 - 10
of 13
pro vyhledávání: '"H R, Silberman"'
Publikováno v:
Blood. 63:639-648
A randomized controlled trial was initiated in 1972 to compare two chemotherapeutic regimens [1–3-bis (2-chloroethyl) 1-nitrosourea (BCNU), cyclophosphamide, and prednisone versus melphalan and prednisone], to determine whether the two regimens are
Publikováno v:
Blood. 54:824-836
Autor:
H. R. Silberman
Publikováno v:
JAMA: The Journal of the American Medical Association. 194:597-600
Autor:
S S, McCachren, H R, Silberman
Publikováno v:
Clinics in geriatric medicine. 3(3)
Until now there has not been a treatise summarizing the management of oncologic emergencies in the aged. All of the well-described acute complications of malignancy occur in the elderly. Such clinical events are best labeled urgent rather than emerge
Autor:
H R, Silberman
Publikováno v:
North Carolina medical journal. 46(3)
Publikováno v:
Archives of pathologylaboratory medicine. 108(12)
Four patients who took the antitumor agent mitomycin manifested microangiopathic hemolytic anemia, thrombocytopenia, and renal failure. At autopsy, kidneys from all four patients had a microangiopathy typical of the hemolytic-uremic syndrome (HUS), w
Publikováno v:
Transactions of the Association of American Physicians. 89
Publikováno v:
Cancer clinical trials. 4(2)
A current southeastern cancer study group protocol for the treatment of multiple myeloma involves induction with BCNU, cyclophosphamide, and prednisone (BCP) and maintenance with either melphalan and prednisone (MP), prednisone, Adriamycin, imuran, a
Autologous marrow transplantation for patients with acute myelogenous leukemia--a preliminary report
Publikováno v:
Experimental hematology. 7
Twelve consecutive adult patients with acute myelogenous leukemia have been entered on a treatment protocol which examines the role of "remission-intensification" during maintenance using high-dose chemoradiotherapy and autologous remission marrow tr
Publikováno v:
Revista venezolana de urologia. 22(3)